TEDA BIOMEDICAL (08189) has announced the appointment of Lynn Li as a Co-Chief Executive Officer of the company. Concurrently, Sun Li has been reassigned from her role as Chief Executive Officer to the position of Co-Chief Executive Officer. These changes will take effect starting March 31, 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.